REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 448 filers reported holding REPLIGEN CORP in Q1 2022. The put-call ratio across all filers is 1.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,339,673 | +109.5% | 14,714 | +86.4% | 0.01% | +150.0% |
| Q2 2023 | $1,116,827 | -66.0% | 7,895 | -59.6% | 0.00% | -66.7% |
| Q1 2023 | $3,288,744 | -73.5% | 19,534 | -73.4% | 0.01% | -77.8% |
| Q4 2022 | $12,432,772 | +3.9% | 73,432 | +14.8% | 0.03% | +17.4% |
| Q3 2022 | $11,966,000 | -46.6% | 63,951 | -46.3% | 0.02% | -36.1% |
| Q1 2022 | $22,390,000 | +10.4% | 119,042 | +55.5% | 0.04% | -14.3% |
| Q4 2021 | $20,275,000 | -4.2% | 76,555 | +4.6% | 0.04% | -10.6% |
| Q3 2021 | $21,154,000 | +5926.8% | 73,200 | +3957.6% | 0.05% | +4600.0% |
| Q1 2021 | $351,000 | -73.2% | 1,804 | -83.0% | 0.00% | -80.0% |
| Q2 2020 | $1,312,000 | +188.4% | 10,617 | +125.2% | 0.01% | +150.0% |
| Q1 2020 | $455,000 | +5587.5% | 4,715 | +3499.2% | 0.00% | – |
| Q1 2019 | $8,000 | – | 131 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 12 West Capital Management LP | 1,021,641 | $295,244,000 | 13.47% |
| Ally Bridge Group (NY) LLC | 70,000 | $20,229,000 | 5.95% |
| Miura Global Management | 85,000 | $24,564,000 | 3.81% |
| Conestoga Capital Advisors, LLC | 871,390 | $251,823,000 | 3.48% |
| Ranger Investment Management | 187,723 | $54,250,000 | 2.90% |
| AWM Investment Company, Inc. | 100,000 | $28,899,000 | 2.84% |
| Brown Capital Management | 1,017,477 | $294,041,000 | 2.41% |
| Stephens Investment Management Group LLC | 558,287 | $161,339,000 | 2.19% |
| Yorktown Management & Research Co Inc | 10,050 | $2,904,000 | 2.18% |
| SV Health Investors, LLC | 14,541 | $4,203,000 | 2.06% |